Business
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue WARREN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced continued progress across its strategic acquisition initiatives intended to complement its existing business
About this update from Tevogen Bio Holdings Inc.
[{"type":"image","alt":"Tevogen Bio Inc","displaySize":"","headline":null,"caption":"Tevogen Bio Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/5d67b8c6f92b49048a1dc80d97a6164f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bOBatWkkUx8ADIQ96Wlo_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMA--/https://media.zenfs.com/en/globenewswire.com/5d67b8c6f92b49048a1dc80d97a6164f","width":300,"height":157},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/bOBatWkkUx8ADIQ96Wlo_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMA--/https://media.zenfs.com/en/globenewswire.com/5d67b8c6f92b49048a1dc80d97a6164f","width":300,"height":157}},"lazy":false},{"type":"text","content":"Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue","length":130,"tagName":"p"},{"type":"image","alt":"Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue","displaySize":"","headline":null,"caption":"Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1200,"height":628,"url":"https://media.zenfs.com/en/globenewswire.com/6a7f2d0e08368b84223a2fa35a534b89"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/X.3MFnHSGo7J7mAezQflCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUwMg--/https://media.zenfs.com/en/globenewswire.com/6a7f2d0e08368b84223a2fa35a534b89","width":960,"height":502},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/EQCgaKOoVYuVcz1OQKo42Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMzNQ--/https://media.zenfs.com/en/globenewswire.com/6a7f2d0e08368b84223a2fa35a534b89","width":640,"height":335},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Ba0YY2FJBJyjtSOw_mTc0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMjU2/https://media.zenfs.com/en/globenewswire.com/6a7f2d0e08368b84223a2fa35a534b89","width":1200,"height":628}}},{"type":"text","content":"WARREN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced continued progress across its strategic acquisition initiatives intended to complement its existing busi...